EUVIMEDEUVIMED entdecken
Open Access

Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy

Elana Ben-Akiva, John W Hickey, Randall A Meyer, Ariel Isser, Sydney R Shannon, Natalie K Livingston, Kelly R Rhodes, Alyssa K Kosmides, Tiarra R Warren, Stephany Y Tzeng, Jonathan P Schneck, Jordan J Green

Acta Biomaterialia · 2023-04 · 160 · 187-197

DOI: 10.1016/j.actbio.2023.02.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-04. Verfasst von Elana Ben-Akiva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Translational Tissue Engineering Center,…. Hauptthemen laut MEDLINE: Melanoma, Nanoparticles. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial antigen presenting cells are biomimetic particles that recapitulate the signals presented by natural antigen presenting cells in order to stimulate T cells in an antigen-specific manner using an acellular platform. We have engineered an enhanced nanoscale biodegradable artificial antigen presenting cell by modulating particle shape to achieve a nanoparticle geometry that allows for increased radius of curvature and surface area for T cell contact. The non-spherical nanoparticle artificial antigen presenting cells developed here have reduced nonspecific uptake and improved circulation time compared both to spherical nanoparticles and to traditional microparticle technologies. Additionally, the anisotropic nanoparticle artificial antigen presenting cells efficiently engage with and activate T cells, ultimately leading to a marked anti-tumor effect in a mouse melanoma model that their spherical counterparts were unable to achieve. STATEMENT OF SIGNIFICANCE: Artificial antigen presenting cells (aAPC) can activate antigen-specific CD8+ T cells but have largely been limited to microparticle-based platforms and ex vivo T cell expansion. Although more amenable to in vivo use, nanoscale aAPC have traditionally been ineffective due to limited surface area available for T cell interaction. In this work, we engineered non-spherical biodegradable nanoscale aAPC to investigate the role of particle geometry and develop a translatable platform for T cell activation. The non-spherical aAPC developed here have increased surface area and a flatter surface for T cell engagement and, therefore, can more effectively stimulate antigen-specific T cells, resulting in anti-tumor efficacy in a mouse melanoma model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNanoparticlesAnimalsMiceAntigen-Presenting CellsLymphocyte ActivationImmunotherapyAntigens

Stichwörter der Autor:innen

Artificial antigen presenting cellBiomimeticCancerImmunoengineeringNanoparticle shape

Substanzen

Antigens

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA…
  • Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Institute for NanoBioTechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Instit…
  • Institute for NanoBioTechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department o…

Förderung

  • NIBIB NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • National Institute of Biomedical Imaging and Bioengineering
  • Johns Hopkins University

Zitieren

APA

Ben-Akiva, E., Hickey, J. W., Meyer, R. A., Isser, A., Shannon, S. R., Livingston, N. K., Rhodes, K. R., Kosmides, A. K., Warren, T. R., Tzeng, S. Y., Schneck, J. P., & Green, J. J. (2023). Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy. Acta Biomaterialia, 160, 187-197. https://doi.org/10.1016/j.actbio.2023.02.023

Vancouver

Ben-Akiva E, Hickey JW, Meyer RA, Isser A, Shannon SR, Livingston NK, et al. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy. Acta Biomaterialia. 2023;160:187-197. doi:10.1016/j.actbio.2023.02.023

BibTeX
@article{BenAkiva2023,
  author = {Ben-Akiva, Elana and Hickey, John W and Meyer, Randall A and Isser, Ariel and Shannon, Sydney R and Livingston, Natalie K and Rhodes, Kelly R and Kosmides, Alyssa K and Warren, Tiarra R and Tzeng, Stephany Y and Schneck, Jonathan P and Green, Jordan J},
  title = {Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {160},
  pages = {187--197},
  doi = {10.1016/j.actbio.2023.02.023}
}
Kostenlos starten →